Puma Biotech Misled Investors About Cancer Trial, Jury Says
A California federal jury has determined that Puma Biotechnology Inc. made misrepresentations in one of four contested statements about the results of a clinical trial involving a breast cancer treatment, awarding...To view the full article, register now.
Already a subscriber? Click here to view full article